Literature DB >> 3158771

Expression of histocompatibility antigens and characterization of mononuclear cell infiltrates in normal and neoplastic colorectal tissues of humans.

H C Umpleby, D Heinemann, M O Symes, R C Williamson.   

Abstract

Serial frozen sections were prepared from 22 colorectal carcinomas. Additional samples were obtained from the adjacent normal bowel in 10 patients, from 6 concomitant adenomas in 5 patients, and from another 4 isolated adenomas. Mononuclear cell infiltrates were stained by the indirect immunoperoxidase technique with the use of a panel of 6 mouse monoclonal antibodies to human leukocyte antigens. The degree of infiltration was graded from 4 (heavy) to 0 (nil). The colorectal carcinomas and adjacent normal bowel showed an equal degree of leukocyte infiltration (HLe-1), graded 3-4 in 8 cases and 2-3 in the other 2 cases. In 7 carcinomas cytotoxic-suppressor T-lymphocytes (UCHT-4) graded 2-3 predominated over helper T-cells (OKT-4) graded 0-1. By contrast, in the adjacent normal bowel cytotoxic and helper cells were present in equal numbers. Among the adenomas leukocyte infiltration was grade 4 in 9 and grade 3 in 1. In 9 of the 10 adenomas cytotoxic cells graded 2 predominated over helper cells graded 0-1. The number of helper cells was equivalent among 6 concomitant adenomas and carcinomas from 5 patients. Adenomatous epithelial cells expressed class II major histocompatibility complex antigens (OKIa-1). However, carcinomatous or normal epithelium showed only faint staining with OKIa-1. The similarity in cell infiltration is consistent with an adenoma-carcinoma sequence. The predominance of cytotoxic cells in carcinomas that expressed class I major histocompatibility complex supports the association between lymphocyte infiltration and a favorable prognosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158771

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  18 in total

1.  Alterations of class I HLA genes in human colon cancers.

Authors:  M Bar-Eli; H Battifora; M J Cline
Journal:  Hum Genet       Date:  1988-01       Impact factor: 4.132

2.  Inhibition of HLA class I antigen and mRNA expression induced by Rous sarcoma virus in transformed human fibroblasts.

Authors:  J Gogusev; B Teutsch; M T Morin; F Mongiat; F Haguenau; G Suskind; G F Rabotti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  Proliferation of T-cell subsets that contact tumour cells in colorectal cancer.

Authors:  S J C Golby; C Chinyama; J Spencer
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

4.  Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cells.

Authors:  F Vánky; G Stuber; S Rotstein; E Klein
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 5.  Experimental strategies for modification of histocompatibility antigens in tumor cells.

Authors:  J Vogel; K Tanaka; G S Hoekzema; G Jay
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma.

Authors:  W M Mulder; E Bloemena; M J Stukart; J A Kummer; J Wagstaff; R J Scheper
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

Review 7.  Chemotherapy and immunotherapy of colorectal cancer.

Authors:  G Masucci; P Ragnhammar; J E Frödin; A L Hjelm; P Wersäll; J Fagerberg; A Osterborg; H Mellstedt
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

8.  Anastomotic leaks in colorectal cancer surgery: a risk factor for recurrence?

Authors:  A M Akyol; J R McGregor; D J Galloway; G D Murray; W D George
Journal:  Int J Colorectal Dis       Date:  1991-11       Impact factor: 2.571

9.  The therapeutic use of the unconjugated monoclonal antibodies (MAb) 17-1A in combination with GM-CSF in the treatment of colorectal carcinoma (CRC).

Authors:  P Ragnhammar; I Magnusson; G Masucci; H Mellstedt
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

10.  Comparison of manually constructed and stapled anastomoses in colorectal surgery. West of Scotland and Highland Anastomosis Study Group.

Authors:  J G Docherty; J R McGregor; A M Akyol; G D Murray; D J Galloway
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.